Nemes Rush Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110 | Hold |
50
| – | – | ﹤0.01% | 704 |
|
|
2025
Q1 | $58 | Hold |
50
| – | – | ﹤0.01% | 695 |
|
|
2024
Q4 | $64 | Hold |
50
| – | – | ﹤0.01% | 716 |
|
|
2024
Q3 | $371 | Hold |
50
| – | – | ﹤0.01% | 575 |
|
|
2024
Q2 | $234 | Hold |
50
| – | – | ﹤0.01% | 587 |
|
|
2024
Q1 | $371 | Hold |
50
| – | – | ﹤0.01% | 635 |
|
|
2023
Q4 | $507 | Hold |
50
| – | – | ﹤0.01% | 623 |
|
|
2023
Q3 | $390 | Hold |
50
| – | – | ﹤0.01% | 619 |
|
|
2023
Q2 | $412 | Buy |
+50
| New | +$412 | ﹤0.01% | 645 |
|